Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Paracetamol 500mg / Ibuprofen 200mg tablets
0407010ADAAAAAA
|
Paracetamol/ibuprofen | Paracetamol and ibuprofen | Central Nervous System | 56 |
|
Nuromol Dual Action Pain Relief 200mg/500mg tablets
0407010ADBBAAAA
|
Nuromol | Paracetamol and ibuprofen | Central Nervous System | 17 |
|
Bell's Dual Action Pain Relief 200mg/500mg tablets
0407010ADBDAAAA
|
Bell's (Paracetamol/ibuprofen) | Paracetamol and ibuprofen | Central Nervous System | No data available |
|
Combogesic 500mg/150mg tablets
0407010ADBCAAAB
|
Combogesic | Paracetamol and ibuprofen | Central Nervous System | No data available |
|
Combogesic Pain Relief 500mg/150mg tablets
0407010ADBCABAB
|
Combogesic | Paracetamol and ibuprofen | Central Nervous System | No data available |
|
Paracetamol 500mg / Ibuprofen 150mg tablets
0407010ADAAABAB
|
Paracetamol/ibuprofen | Paracetamol and ibuprofen | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.